Furthermore, the AR can up-regulate the expression of the tumor suppressor protein, estrogen receptors beta (ERβ), to indirectly inhibit the biological activity of ERα and down-regulate the expression level of the proto-oncogene CCND1, or may enhance other tumor suppressors, including FOXO1 and FOXO3a [20,21]. The gene discussed is ESR2; the disease is neoplasm.